Tarsus Pharmaceuticals, Inc. (TARS) SEC filings
TARSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/304% above fair value
$78.20−0.48 (-0.61%)
Close on Nov 17, 2026Market cap $3.43BP/E –Yield 0.00%
SEC filings
40 of Tarsus Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 3, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2026 | Nov 3, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2026 | Sep 10, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 13, 2026 | Jul 13, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 6, 2026 | Jul 8, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 25, 2026 | Apr 28, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 18, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 12, 2025 | Jun 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 1, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 12, 2025 | Apr 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 14, 2025 | Mar 18, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 12, 2025 | Mar 13, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Feb 25, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 15, 2025 | Jan 17, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2024 | Dec 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 13, 2024 | Nov 13, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2024 | Nov 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 8, 2024 | Aug 8, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 13, 2024 | Jun 18, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 8, 2024 | May 8, 2024 | SEC EDGAR |
See a number that looks wrong?